Blog

Thomas LeBlanc: I signed ASCO’s letter to end the drug shortage crisis

Photo from Thomas LeBlanc/X

Feb 29, 2024, 05:15

Thomas LeBlanc: I signed ASCO’s letter to end the drug shortage crisis

Thomas LeBlanc, Chief Patient Experience and Safety Officer for the Duke Cancer Institute, shared on X/Twitter:

“I signed ASCO’s letter from America’s cancer doctors and providers urging policymakers to end the drug shortage crisis. Patients are still struggling to get the treatments they need.

Add your voice to the push for solutions and sign the letter!”

Further details.
Source: Thomas LeBlanc/X

ASCO ASCO Advocacy cancer cancer treatment drug shortage Duke Cancer Institute medical advocacy OncoDaily Oncology policy change public health Thomas LeBlanc

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage